Ignite Creation Date:
2025-12-26 @ 2:38 PM
Ignite Modification Date:
2025-12-26 @ 2:38 PM
Study NCT ID:
NCT04890106
Status:
COMPLETED
Last Update Posted:
2022-12-13
First Post:
2021-05-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma
Sponsor:
Mankind Pharma Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-11
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-12
First Submit QC Date:
None
Study First Post Date:
2021-05-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-12
Last Update Post Date:
2022-12-13
Last Update Post Date Type:
ACTUAL